Two experimental Ebola treatments, including a drug from Regeneron, are advancing to the next stage of a large clinical trial after an independent committee determined …
Following the recent announcement from the WHO that Merck’s experimental Ebola vaccine V920 (rVSV-ZEBOV) will be offered to pregnant women in the Congo for the …
Activase (alteplase) is currently the only FDA-approved drug available for the treatment of acute ischemic stroke (AIS) in the 8MM*; however, novel drugs designed to …
Following a study published in The Lancet Oncology regarding a brand new type of cancer drug that has shown promise in multiple cancer types in …
Despite the ophthalmology market experiencing several research and development (R&D) setbacks during 2018, the launch of three new drugs highlights that the market still offers …
After decades a new drug against malaria has been developed and first clinical trials of this new investigational drug is soon to begin. Enrolment for …
Journal For Clinical Studies has a distinguished editorial advisory board providing the best guidelines for global clinical trials. Your resource for Multisite Studies and emerging markets.
